Monday, August 17, 2020

Newtopia Inc. - NEWU.v

Newtopia Inc. - NEWU.v works closely with organizations and their employees to deliver highly personalized and targeted disease prevention solutions that are proven to reduce employer healthcare costs. Newtopia delivers sustainable clinical and financial outcomes.

On August 12, 2020 the company released Numbers

Newtopia Inc. has released its financial results for the second quarter of 2020.
"Amidst one of the most challenging financial quarters on record, we are very pleased to report record levels of engagement that drove second quarter revenue of $2.69 million and gross profit of $1.41 million. In the first six months of 2020, we have already exceeded revenue and gross profit1 for all of 2019 -- an important achievement as we commenced trading as a public company in the quarter. It is a testament to a fundamental shift taking place in the health care sector toward virtual care and disease prevention," said Jeff Ruby, founder and chief executive officer.

Wednesday, August 12, 2020

Crescita Therapeutics Inc - CTX.v

Crescita Therapeutics Inc - CTX.v owns a portfolio of non-prescription skincare products and has one FDA approved prescription product, Pliaglis. Crescita owns the sales and marketing rights in over 20 countries available for out-licensing.

On Aug 12, 2020 the company released Numbers

  • Revenue was $1,733, a decrease of $7,629. In Q2-F2019, the Company recognized $5,459 in up-front payments and guaranteed future minimum royalties in connection with the out-licensing agreement with Cantabria Labs ("Cantabria" and the "Cantabria Agreement");
  • Gross profit was $1,092, representing a gross margin of 63.0%;
  • Operating expenses (excluding COGS) were $2,318, a decrease of $1,012;
  • Recorded a non-cash impairment charge on intangible assets of $1,918 to reflect the projected impact of the pandemic-driven decrease in demand for certain products and services;
  • Adjusted EBITDA1 was $(781), a decrease of $5,864, mainly due to the revenue recognized in connection with the Cantabria Agreement in Q2-F2019 of $5,459;
  • Ending cash position was $9,265, a decrease of $69 versus Q1-F2020 and flat versus Q4-F2019.

Wednesday, August 5, 2020

Bluma Wellness Inc. - BWEL.U

Bluma Wellness Inc. - BWEL.U assembled one of the most experienced and talented teams in cannabis cultivation in the world. The talent made it clear that they were only willing to go on this journey to be the best, not the biggest.

The company's goal is a significant increase in the available premium cannabis product to sell to its customers after recent investment in cultivation and processing facilities in Florida. The company operates 4 stores with plans for 10 by the end of Q4. Production has gone from 300 pounds a month to 1,500 pounds a month.

On July 24, 2020 the company released News 

Bluma Wellness Inc. has agreed to issue 4,480,238 non-transferable common share purchase warrants to AFC Warehouse LLC (also known as Advanced Flower Capital) pursuant to the terms and conditions of the existing $15-million (U.S.) non-revolving, staged advance loan between Advanced Flower Capital and CannCure Investments Inc., a subsidiary of the company. The construction loan is being used, in part, to finance the expansion and completion of the company's facilities at the Indiantown greenhouse facility.

Saturday, August 1, 2020

mCloud Technologies Corp. - MCLD.v

mCloud Technologies Corp. - MCLD.v is a leading provider of asset management solutions combining IoT, cloud computing, and artificial intelligence. ("AI") mCloud's AI-powered AssetCare™ platform offers complete asset management solutions.

On July 28, 2020 the company released News 

mCloud Technologies Corp. today announced it had added 2,675 assets to its portfolio under management in the second quarter of 2020 to reach a total of 51,347 connected assets while working under the severely restricted commercial conditions imposed by COVID-19. This represents an 83% increase in total connected assets over the same period last year.